253 related articles for article (PubMed ID: 21804608)
21. Synthesis and evaluation of novel N1-acylated 5-(4-pyridinyl)indazole derivatives as potent and selective haspin inhibitors.
Shawky MM; Abdallah M; Khalifa H; Aboushady Y; Abadi AH; Engel M; Abdel-Halim M
Bioorg Chem; 2024 Apr; 145():107235. PubMed ID: 38447464
[TBL] [Abstract][Full Text] [Related]
22. A small-molecule inhibitor of Haspin alters the kinetochore functions of Aurora B.
De Antoni A; Maffini S; Knapp S; Musacchio A; Santaguida S
J Cell Biol; 2012 Oct; 199(2):269-84. PubMed ID: 23071153
[TBL] [Abstract][Full Text] [Related]
23. HASPIN kinase inhibitor CHR-6494 suppresses intestinal polyp development, cachexia, and hypogonadism in Apcmin/+ mice.
Tanaka H; Wada M; Park J
Eur J Cancer Prev; 2020 Nov; 29(6):481-485. PubMed ID: 31833958
[TBL] [Abstract][Full Text] [Related]
24. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
Matsuhashi A; Ohno T; Kimura M; Hara A; Saio M; Nagano A; Kawai G; Saitou M; Takigami I; Yamada K; Okano Y; Shimizu K
Curr Cancer Drug Targets; 2012 Jul; 12(6):625-39. PubMed ID: 22463590
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity.
Melms JC; Vallabhaneni S; Mills CE; Yapp C; Chen JY; Morelli E; Waszyk P; Kumar S; Deming D; Moret N; Rodriguez S; Subramanian K; Rogava M; Cartwright ANR; Luoma A; Mei S; Brinker TJ; Miller DM; Spektor A; Schadendorf D; Riggi N; Wucherpfennig KW; Sorger PK; Izar B
Cancer Res; 2020 Feb; 80(4):798-810. PubMed ID: 31882401
[TBL] [Abstract][Full Text] [Related]
26. Distinct roles of haspin in stem cell division and male gametogenesis.
Soupsana K; Karanika E; Kiosse F; Christogianni A; Sfikas Y; Topalis P; Batistatou A; Kanaki Z; Klinakis A; Politou AS; Georgatos S
Sci Rep; 2021 Oct; 11(1):19901. PubMed ID: 34615946
[TBL] [Abstract][Full Text] [Related]
27. A positive feedback loop involving Haspin and Aurora B promotes CPC accumulation at centromeres in mitosis.
Wang F; Ulyanova NP; van der Waal MS; Patnaik D; Lens SM; Higgins JM
Curr Biol; 2011 Jun; 21(12):1061-9. PubMed ID: 21658950
[TBL] [Abstract][Full Text] [Related]
28. Sangivamycin and its derivatives inhibit Haspin-Histone H3-survivin signaling and induce pancreatic cancer cell death.
Bastea LI; Hollant LMA; Döppler HR; Reid EM; Storz P
Sci Rep; 2019 Nov; 9(1):16588. PubMed ID: 31719634
[TBL] [Abstract][Full Text] [Related]
29. Co-crystal structures of the protein kinase haspin with bisubstrate inhibitors.
Lavogina D; Kestav K; Chaikuad A; Heroven C; Knapp S; Uri A
Acta Crystallogr F Struct Biol Commun; 2016 May; 72(Pt 5):339-45. PubMed ID: 27139824
[TBL] [Abstract][Full Text] [Related]
30. Coumestrol Epigenetically Suppresses Cancer Cell Proliferation: Coumestrol Is a Natural Haspin Kinase Inhibitor.
Kim JE; Lee SY; Jang M; Choi HK; Kim JH; Chen H; Lim TG; Dong Z; Lee KW
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064398
[TBL] [Abstract][Full Text] [Related]
31. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
[TBL] [Abstract][Full Text] [Related]
32. Slowly on, Slowly off: Bisubstrate-Analogue Conjugates of 5-Iodotubercidin and Histone H3 Peptide Targeting Protein Kinase Haspin.
Kestav K; Viht K; Konovalov A; Enkvist E; Uri A; Lavogina D
Chembiochem; 2017 Apr; 18(8):790-798. PubMed ID: 28181383
[TBL] [Abstract][Full Text] [Related]
33. Aurora B kinase inhibition in mitosis: strategies for optimising the use of aurora kinase inhibitors such as AT9283.
Curry J; Angove H; Fazal L; Lyons J; Reule M; Thompson N; Wallis N
Cell Cycle; 2009 Jun; 8(12):1921-9. PubMed ID: 19440047
[TBL] [Abstract][Full Text] [Related]
34. TAK-960, a novel, orally available, selective inhibitor of polo-like kinase 1, shows broad-spectrum preclinical antitumor activity in multiple dosing regimens.
Hikichi Y; Honda K; Hikami K; Miyashita H; Kaieda I; Murai S; Uchiyama N; Hasegawa M; Kawamoto T; Sato T; Ichikawa T; Cao S; Nie Z; Zhang L; Yang J; Kuida K; Kupperman E
Mol Cancer Ther; 2012 Mar; 11(3):700-9. PubMed ID: 22188812
[TBL] [Abstract][Full Text] [Related]
35. SUMOylation of DNA topoisomerase IIα regulates histone H3 kinase Haspin and H3 phosphorylation in mitosis.
Yoshida MM; Ting L; Gygi SP; Azuma Y
J Cell Biol; 2016 Jun; 213(6):665-78. PubMed ID: 27325792
[TBL] [Abstract][Full Text] [Related]
36. CS2164, a novel multi-target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti-tumor potency.
Zhou Y; Shan S; Li ZB; Xin LJ; Pan DS; Yang QJ; Liu YP; Yue XP; Liu XR; Gao JZ; Zhang JW; Ning ZQ; Lu XP
Cancer Sci; 2017 Mar; 108(3):469-477. PubMed ID: 28004478
[TBL] [Abstract][Full Text] [Related]
37. Yeast haspin kinase regulates polarity cues necessary for mitotic spindle positioning and is required to tolerate mitotic arrest.
Panigada D; Grianti P; Nespoli A; Rotondo G; Castro DG; Quadri R; Piatti S; Plevani P; Muzi-Falconi M
Dev Cell; 2013 Sep; 26(5):483-95. PubMed ID: 23973165
[TBL] [Abstract][Full Text] [Related]
38. Regulation of mitotic chromosome cohesion by Haspin and Aurora B.
Dai J; Sullivan BA; Higgins JM
Dev Cell; 2006 Nov; 11(5):741-50. PubMed ID: 17084365
[TBL] [Abstract][Full Text] [Related]
39. Aurora B defines its own chromosomal targeting by opposing the recruitment of the phosphatase scaffold Repo-Man.
Qian J; Beullens M; Lesage B; Bollen M
Curr Biol; 2013 Jun; 23(12):1136-43. PubMed ID: 23746640
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide CRISPR screen uncovers a synergistic effect of combining Haspin and Aurora kinase B inhibition.
Huang M; Feng X; Su D; Wang G; Wang C; Tang M; Paulucci-Holthauzen A; Hart T; Chen J
Oncogene; 2020 May; 39(21):4312-4322. PubMed ID: 32300176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
